Profile data is unavailable for this security.
About the company
Benson Hill, Inc. is an ag-tech company. The Company offers CropOS, which is a product design and development platform that uses predictive breeding and other advanced tools like CRISPR gene editing technology. The Company is engaged in the sale of soybean grain, soybean oil, soybean meal, soybean flakes and soybean flour and texturized flour, sales of processed yellow peas and sales of seed, as well as technology licensing fees and royalties. Its CropOS platform aggregates proprietary protein, genomic, and strategic data layers for predictive breeding using artificial intelligence (AI) and machine learning (ML) and its Crop Accelerator, an indoor year-round speed breeding and rapid prototyping facility. It is developing a diversified seed portfolio spanning the key markets, such as protein ingredients, aquaculture and specialty animal feed, and vegetable oils. The Company sells its products throughout North America, in Europe and in several countries globally.
- Revenue in USD (TTM)359.83m
- Net income in USD-132.72m
- Incorporated2020
- Employees270.00
- LocationBenson Hill Inc1001 N. Warson Rd., Ste 300ST. LOUIS 63132United StatesUSA
- Phone+1 (314) 222-8218
- Fax+1 (302) 655-5049
- Websitehttps://bensonhill.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fortress Biotech Inc | 85.11m | -62.86m | 36.65m | 186.00 | -- | 1.55 | -- | 0.4306 | -6.65 | -6.65 | 7.96 | 1.19 | 0.3976 | 2.27 | 4.55 | 457,602.20 | -64.47 | -52.50 | -107.85 | -99.46 | 68.25 | 63.17 | -162.17 | -236.94 | 1.21 | -10.18 | 1.07 | -- | 11.58 | 25.75 | 27.42 | -- | -9.37 | -- |
| Xilio Therapeutics Inc | 0.00 | -70.96m | 37.65m | 73.00 | -- | 1.36 | -- | -- | -2.57 | -2.57 | 0.00 | 0.7474 | 0.00 | -- | -- | 0.00 | -73.11 | -- | -96.98 | -- | -- | -- | -- | -- | -- | -144.29 | 0.00 | -- | -- | -- | 13.40 | -- | -- | -- |
| Lipocine Inc | 4.71m | -8.97m | 37.70m | 17.00 | -- | 1.56 | -- | 8.00 | -1.71 | -1.71 | 0.8889 | 4.51 | 0.1585 | -- | 67.70 | 277,138.80 | -30.16 | -39.32 | -32.00 | -45.87 | -- | -- | -190.35 | -442.26 | -- | -- | 0.00 | -- | -670.16 | -- | -51.99 | -- | -- | -- |
| Cara Therapeutics Inc | 16.94m | -122.54m | 38.01m | 55.00 | -- | 1.28 | -- | 2.24 | -2.26 | -2.26 | 0.3118 | 0.5452 | 0.1392 | 1.34 | 4.35 | 307,963.60 | -100.70 | -35.76 | -115.83 | -40.82 | 75.18 | -- | -723.49 | -162.10 | 5.20 | -- | 0.00 | -- | -49.92 | 9.26 | -38.65 | -- | 100.66 | -- |
| NRX Pharmaceuticals Inc | 0.00 | -25.65m | 38.09m | 2.00 | -- | -- | -- | -- | -2.06 | -2.06 | 0.00 | -1.54 | 0.00 | -- | -- | -- | -200.56 | -120.57 | -- | -168.40 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 24.14 | -- | -- | -- |
| NextCure Inc | 0.00 | -63.73m | 38.60m | 82.00 | -- | 0.3888 | -- | -- | -2.29 | -2.29 | 0.00 | 3.55 | 0.00 | -- | -- | 0.00 | -45.05 | -22.59 | -47.72 | -23.54 | -- | -- | -- | -964.96 | -- | -- | 0.00 | -- | -- | -- | 16.07 | -- | -23.17 | -- |
| Acurx Pharmaceuticals Inc | 0.00 | -16.05m | 38.82m | 4.00 | -- | 6.44 | -- | -- | -1.17 | -1.17 | 0.00 | 0.3807 | 0.00 | -- | -- | 0.00 | -194.65 | -- | -283.87 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -20.55 | -- | -- | -- |
| Benson Hill Inc | 359.83m | -132.72m | 39.22m | 270.00 | -- | 0.5828 | -- | 0.109 | -0.7033 | -0.7082 | 1.90 | 0.3174 | 1.13 | 9.80 | 20.67 | 1,332,689.00 | -41.85 | -- | -49.16 | -- | 5.38 | 3.18 | -36.88 | -40.73 | 2.02 | -2.12 | 0.183 | -- | 24.16 | 156.43 | -11.58 | -- | 63.78 | -- |
| Mink Therapeutics Inc | 0.00 | -20.59m | 39.37m | 31.00 | -- | -- | -- | -- | -0.5964 | -0.5964 | 0.00 | -0.585 | 0.00 | -- | -- | 0.00 | -175.32 | -- | -3,661.37 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 19.77 | -- | -- | -- |
| Hcw Biologics Inc | 3.93m | -27.39m | 39.81m | 45.00 | -- | 4.55 | -- | 10.14 | -0.7547 | -0.7547 | 0.1083 | 0.2311 | 0.1062 | -- | 6.79 | 87,258.22 | -74.07 | -- | -97.78 | -- | 29.61 | -- | -697.59 | -- | -- | -146.89 | 0.4863 | -- | -57.72 | -- | -67.74 | -- | -- | -- |
| Reviva Pharmaceuticals Holdings, Inc. | 0.00 | -40.09m | 40.25m | 15.00 | -- | -- | -- | -- | -1.60 | -1.60 | 0.00 | -0.0482 | 0.00 | -- | -- | 0.00 | -303.75 | -- | -1,499.90 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -38.92 | -- | -- | -- |
| Natural Alternatives International, Inc. | 120.20m | -3.31m | 40.31m | 317.00 | -- | 0.4793 | 30.03 | 0.3353 | -0.5646 | -0.5646 | 20.53 | 13.56 | 0.8091 | 3.63 | 12.77 | 379,183.00 | -2.23 | 4.90 | -2.56 | 5.93 | 8.85 | 15.98 | -2.75 | 3.80 | 2.44 | -2.71 | 0.0996 | 0.00 | -9.91 | 3.06 | -76.46 | -20.74 | 27.08 | -- |
| Matinas BioPharma Holdings Inc | 0.00 | -23.25m | 40.38m | 32.00 | -- | 2.41 | -- | -- | -0.107 | -0.107 | 0.00 | 0.0669 | 0.00 | -- | -- | 0.00 | -80.36 | -44.62 | -86.16 | -48.25 | -- | -- | -- | -2,344.60 | -- | -- | 0.0014 | -- | -65.62 | 55.71 | -9.26 | -- | -16.46 | -- |
| Immuneering Corp | 0.00 | -54.18m | 40.92m | 65.00 | -- | 0.5198 | -- | -- | -1.86 | -1.86 | 0.00 | 2.65 | 0.00 | -- | -- | 0.00 | -55.37 | -- | -58.58 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -100.00 | -- | -5.86 | -- | -- | -- |
| Eyenovia Inc | 8.78k | -32.44m | 41.48m | 57.00 | -- | 20.07 | -- | 4,724.43 | -0.7448 | -0.7448 | 0.0002 | 0.0384 | 0.0003 | -- | 0.008 | 154.04 | -116.94 | -80.31 | -190.14 | -117.70 | 0.00 | -- | -369,519.70 | -680.95 | 0.6645 | -16.03 | 0.8914 | -- | -- | -- | 2.68 | -- | 152.20 | -- |
Data as of Jun 10 2024. Currency figures normalised to Benson Hill Inc's reporting currency: US Dollar USD
22.05%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Builders Vision LLCas of 30 Apr 2024 | 11.22m | 5.31% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 10.06m | 4.76% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 8.13m | 3.85% |
| The Caisse de d�p�t et placement du Qu�becas of 31 Mar 2024 | 5.10m | 2.42% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 3.00m | 1.42% |
| Geode Capital Management LLCas of 31 Mar 2024 | 3.00m | 1.42% |
| Fortem Financial Group LLCas of 31 Mar 2024 | 2.95m | 1.40% |
| Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 2024 | 1.23m | 0.59% |
| Cohen & Steers Capital Management, Inc.as of 31 Mar 2024 | 962.50k | 0.46% |
| Charles Schwab Investment Management, Inc.as of 31 Mar 2024 | 896.19k | 0.43% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
